Avatrombopag, an investigational thrombopoietin-receptor agonist, is effective in persistent and chronic immune thrombocytopenia and stimulates platelet production.
Keywords: Color, 3D, Advertising / Marketing, Disease Management, Mechanism of Action (MOA)
© Jackie Heda
